# FDA Inspection 1034691 - Pharmanalytica SA - September 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/pharmanalytica-sa/5cfc57bf-a201-4cf6-a114-038be27372ad
Source feed: FDA_Inspections

> FDA Inspection 1034691 for Pharmanalytica SA on September 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1034691
- Company Name: Pharmanalytica SA
- Inspection Date: 2017-09-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1205219 - 2023-03-29](https://www.keypedia.com/records/fda_inspections/pharmanalytica-sa/2c33c757-e50e-4b08-96df-83c3d0e20f36)
- [FDA Inspection 938818 - 2015-07-17](https://www.keypedia.com/records/fda_inspections/pharmanalytica-sa/a1bf17a9-510b-4786-aa66-4090c4b1da0f)
- [FDA Inspection 747929 - 2011-09-23](https://www.keypedia.com/records/fda_inspections/pharmanalytica-sa/c523278f-ffaa-4228-82ce-dd05ee7d6fed)

Company: https://www.keypedia.com/companies/pharmanalytica-sa/29f97d4d-bcad-46bc-be9e-311ad3b7f399

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c